This technology is an automated, high-throughput epigenomic mapping method that leverages chromatin immunoprecipitation-sequencing (ChIP-seq) to comprehensively profile chromatin states of low-cell input samples.
This technology describes a distinct class of ibogaine analogs created by chemical synthesis that maintains the pharmacological benefits of ibogaine with reduced cardiac adverse effects.
This technology is an in vitro platform of genetically engineered live yeasts for rapid and sensitive detection of pathogens, including fungal species, viruses, and protein variants.
